Literature DB >> 1609769

Plasma cytokine levels in thrombotic thrombocytopenic purpura.

H Wada1, T Kaneko, M Ohiwa, M Tanigawa, S Tamaki, N Minami, H Takahashi, K Deguchi, T Nakano, S Shirakawa.   

Abstract

Plasma cytokine levels were examined in 13 patients with thrombotic thrombocytopenic purpura (TTP). Auto-antibodies, platelet-associated immunoglobulin G, and platelet aggregating factor were detected in many of these patients and high-molecular-weight bands of von Willebrand factor multimers were reduced in 9 of 10 patients examined. Complete remission (CR) was attained in 7 of the 13 patients, but 6 died. Tumor necrosis factor (TNF), Interleukin (IL)-1 beta, IL-6, and soluble IL-2 receptor showed marked increases at onset and decreased at CR. The prognosis tended to be poor in patients with increased IL-6 and soluble IL-2 receptor levels. These findings suggest that immunological mechanisms, such as the activation of macrophage, are involved in the pathogenesis of TTP and are reflected in the plasma cytokine levels.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1609769     DOI: 10.1002/ajh.2830400303

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  9 in total

1.  Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells.

Authors:  Juliane Gust; Kevin A Hay; Laïla-Aïcha Hanafi; Daniel Li; David Myerson; Luis F Gonzalez-Cuyar; Cecilia Yeung; W Conrad Liles; Mark Wurfel; Jose A Lopez; Junmei Chen; Dominic Chung; Susanna Harju-Baker; Tahsin Özpolat; Kathleen R Fink; Stanley R Riddell; David G Maloney; Cameron J Turtle
Journal:  Cancer Discov       Date:  2017-10-12       Impact factor: 39.397

2.  Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura.

Authors:  D Karpman; A Andreasson; H Thysell; B S Kaplan; C Svanborg
Journal:  Pediatr Nephrol       Date:  1995-12       Impact factor: 3.714

3.  Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid.

Authors:  L L Cooling; K E Walker; T Gille; T A Koerner
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

4.  Synergistic interactions between interferon-gamma and TRAIL modulate c-FLIP in endothelial cells, mediating their lineage-specific sensitivity to thrombotic thrombocytopenic purpura plasma-associated apoptosis.

Authors:  Radu Stefanescu; Dustin Bassett; Rozbeh Modarresi; Francisco Santiago; Mohamad Fakruddin; Jeffrey Laurence
Journal:  Blood       Date:  2008-03-13       Impact factor: 22.113

5.  Inflammatory cytokines inhibit ADAMTS13 synthesis in hepatic stellate cells and endothelial cells.

Authors:  W J Cao; M Niiya; X W Zheng; D Z Shang; X L Zheng
Journal:  J Thromb Haemost       Date:  2008-07-01       Impact factor: 5.824

6.  Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura.

Authors:  Contessa E Edgar; Deirdra R Terrell; Sara K Vesely; Jonathan D Wren; Igor M Dozmorov; Timothy B Niewold; Michael Brown; Fang Zhou; Mark Barton Frank; Joan T Merrill; Johanna A Kremer Hovinga; Bernhard Lämmle; Judith A James; James N George; A Darise Farris
Journal:  PLoS One       Date:  2015-02-11       Impact factor: 3.240

7.  Increased prothrombotic property as a risk factor of acute kidney injury after surgical repair of abdominal aortic aneurysm: a prospective observational study.

Authors:  Yasushi Innami; Nobuyuki Katori; Katsuya Mori; Shizuko Kosugi; Takeshi Suzuki; Norihiro Sakurai; Hiromasa Nagata; Junzo Takeda; Hiroshi Morisaki
Journal:  J Intensive Care       Date:  2014-07-16

Review 8.  Methylene blue-treated plasma, versus quarantine fresh frozen plasma, for acute thrombotic thrombocytopenic purpura treatment: Comparison between centres and critical review on longitudinal data.

Authors:  José Luis Arroyo; Eva Martínez; Cristina Amunárriz; Carmen Muñoz; Iñigo Romón; Ignacio Álvarez; José María García
Journal:  Transfus Apher Sci       Date:  2020-04-12       Impact factor: 1.764

Review 9.  Proteolytic processing of von Willebrand factor by adamts13 and leukocyte proteases.

Authors:  Stefano Lancellotti; Maria Basso; Raimondo De Cristofaro
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-09-02       Impact factor: 2.576

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.